merged_engineered-virus-steals-proteins-from-hiv.txt
<question_number>1</question_number>
<answer>Daily doses of protease inhibitors are too expensive for most people with H.I.V. to rely on.</answer>

<question_number>2</question_number>
<answer>It might make it harder for people to transmit H.I.V. to others.</answer>

<question_number>3</question_number>
<answer>TIPs inserts themselves into the DNA of a patient's immune cells, becoming a permanent part of their bodies.</answer>

<question_number>4</question_number>
<answer>TIPs can reduce H.I.V. to very low levels by outcompeting the virus for resources, whereas protease inhibitors prevent a protein from activating H.I.V.</answer>

<question_number>5</question_number>
<answer>The potential for unexpected side effects that cannot be removed.</answer>

<question_number>6</question_number>
<answer>TIPs can replicate and produce more TIPs than H.I.V. viruses when both are present in an infected cell.</answer>

<question_number>7</question_number>
<answer>The potential for unexpected side effects that cannot be removed.</answer>

<question_number>8</question_number>
<answer>The strategy of using cheating viruses could be applied to other viruses.</answer>

<question_number>9</question_number>
<answer>It raises the issue of obtaining consent from others who might be infected with TIPs.</answer>

<question_number>10</question_number>
<answer>TIPs interfere with H.I.V.'s normal life cycle by outcompeting the virus for resources, whereas traditional drugs like protease inhibitors target specific viral proteins.</answer>